Michael Ball

Executive Advisor, Canexia Health

Michael is Founder and CEO of Marketech Solutions, providing strategic expertise in the precision health, life sciences, genomics and diagnostics industries. Clients include early & mid-stage high growth organizations, private equity and venture capitalists. Previously, Michael was the CEO of Canexia Health a clinical diagnostics company specializing in liquid biopsy testing for cancer patients. Michael is an accomplished B2B executive with a history of scaling global companies from startup, through acquisition and IPO. Prior to Canexia Health, he was the Global VP Informatics at Illumina, a $50B leader in the Genomics space. He was also the CEO of GenoLogics a venture backed start-up which was sold to Illumina. Michael served on the leadership team at Creo Products, during which time they executed a successful IPO. Michael is also active as an advisor and board member on companies in the Digital Health sector.